Oxfordshire, UK — October 27, 2005
— Celoxica, the leading provider of C-based electronic system level (ESL) design and synthesis solutions today announced its admission to the Alternative Investment Market (AIM) of the London Stock Exchange (LSE) and the commencement of trading in its Ordinary Shares. Trading under the symbol CXA, the Company raised £6.1M ($10.9M USD).
Based in the UK near Oxford, Celoxica is the leading provider of electronic system level (ESL) design and synthesis solutions used for the design and development of complex electronic products and embedded systems. According to Gartner, ESL is set to become a major driver of growth for the broader electronic design automation (EDA) market and could be worth as much as $1.6 billion by 2009. Celoxica addresses a key requirement in the success of ESL; the implementation of hardware directly from complex algorithms written in C-software descriptions.
“We are pleased that the investment community has recognized our potential and AIM listing is an important step in Celoxica’s strategic development,” said Phil Bishop, CEO of Celoxica. “The growing complexity of digital electronics combined with challenging and aggressive development schedules are increasing the demand for our design solutions, a trend that is predicted to continue” About Celoxica
An innovator in Electronic System Level (ESL) design, Celoxica is turning software into silicon by supplying the design tools, boards, IP and services that enable the next generation of advanced electronic product design. Celoxica technology raises design abstraction to the algorithm level, accelerating productivity and lowering risk and costs by generating semiconductor hardware directly from C-based software descriptions. Adding to a growing installed base, Celoxica provides the world’s most widely used C-based behavioral design and synthesis solutions to companies developing semiconductor products in markets such as consumer electronics, defense and aerospace, automotive, industrial and security. For more information, visit: www.celoxica.com